1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro

Area of Science:

• Immunology
• Endocrinology

Background:

• B cells play a crucial role in immune responses, including immunoglobulin synthesis.
• Vitamin D (VD) is a steroid hormone with known immunomodulatory effects.
• The vitamin D receptor (VDR) is expressed in various immune cells, but its role in B cell function requires further elucidation.

Purpose of the Study:

• To investigate the effects of vitamin D (VD) and its analogue EB1089 on anti-CD40+IL-4-stimulated B cell proliferation and immunoglobulin synthesis.
• To explore the underlying mechanisms of VD's action on IgE production in B cells.

Main Methods:

• B cells from healthy donors were stimulated with anti-CD40 and IL-4.
• Vitamin D receptor (VDR) expression was analyzed.
• B cell proliferation and immunoglobulin (IgA, IgG, IgM, IgE) synthesis were measured in the presence of VD or EB1089.
• Intracellular staining was used to quantify IgE-producing cells.
• Expression of CD23, IL-6, epsilon germ-line transcription, and NF-kappaB activation was assessed.

Main Results:

• VDR expression was detected only in stimulated B cells.
• VD and EB1089 did not affect anti-CD40+IL-4-mediated B cell proliferation.
• IgE synthesis was significantly inhibited by VD and EB1089, with maximal inhibition at 10(-6) M.
• Other Ig productions (IgA, IgG, IgM) were not significantly affected or only slightly reduced.
• VD inhibited epsilon germ-line transcription and NF-kappaB (p50 and p65) protein expression.

Conclusions:

• Vitamin D (VD) and its analogue EB1089 effectively inhibit IgE production in anti-CD40+IL-4-stimulated B cells in vitro.
• The mechanism of inhibition involves downregulation of epsilon germ-line transcription and NF-kappaB activation.
• These findings highlight a specific immunomodulatory role of VD in regulating IgE synthesis through complex cellular pathways.